Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study

Jannik Langtved Pallisgaard, Tommi Bo Lindhardt, Morten Lock Hansen, Anne-Marie Schjerning, Jonas Bjerring Olesen, Laila Staerk, Christian Torp-Pedersen, Gunnar Hilmar Gislason

Research output: Contribution to journalJournal articleResearchpeer-review

30 Citations (Scopus)
342 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cardioversion and risk of adverse events with dabigatran versus warfarin: a nationwide cohort study'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science